Compartmentalization of tolerance to endotoxin

Journal of Infectious Diseases

Volumn 189, Issue 7, 2004, Pages 1295-1303

  Fitting, Catherine ^a   Dhawan, Suman ^a,b   Cavaillon, Jean Marc ^a  

^a INSTITUT PASTEUR   (France)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BONE MARROW CELL; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; CROSS TOLERANCE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; SPLEEN CELL; STAPHYLOCOCCUS AUREUS;

ANIMALS; BONE MARROW CELLS; ESCHERICHIA COLI; GLUCOCORTICOIDS; IMMUNE TOLERANCE; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MIFEPRISTONE; SPLEEN; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1842555390     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/382657     Document Type: Article

References (67)

1. Beeson PB. Development of tolerance to typhoid bacterial pyrogen and its abolition by reticulo-endothelial blockade. Proc Soc Exp Biol Med 1946; 61:248-50.
2. Neva FA, Morgan HR. Tolerance to the action of endotoxin of enteric bacilli in patients convalescent from typhoid and paratyphoid fevers. J Lab Clin Med 1950; 35:911-22.
3. McCabe WR. Endotoxin tolerance. II. Its occurrence in patients with pyelonephritis. J Clin Invest 1963; 42:618-25.
4. Mathison JC, Virca GD, Wolfson E, Tobias PS, Glaser K, Ulevitch RJ. Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest 1990; 85:1108-18.
5. Rayhane N, Fitting C, Cavaillon J-M. Dissociation of INF-γ from IL-12 and IL-18 during endotoxin tolerance. J Endotoxin Res 1999; 5:319-24.
6. Astiz ME, Rackow EC, Still JG, et al. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective double blind, randomized, controlled trial. Crit Care Med 1995; 23:9-17.
7. Freudenberg MA, Galanos C. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun 1988; 56:1352-7.
8. Haas JG, Baeuerle PA, Riethmüller G, Ziegler-Heitbrock HWL. Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc Natl Acad Sci USA 1990; 87:9563-7.
9. Virca GD, Kim SY, Glaser KB, Ulevitch RJ. Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. J Biol Chem 1989; 264:21951-6.
10. Takasuka N, Tokunaga T, Akagawa KS. Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-α mRNA but not of IL-1β mRNA. J Immunol 1991; 146:3824-30.
11. Cavaillon JM, Pitton C, Fitting C. Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGFβ. J Endotoxin Res 1994; 1:21-9.
12. Evans GF, Zuckerman SH. Glucocorticoid-dependent and independent mechanisms involved in lipopolysaccahride tolerance. Eur J Immunol 1991; 21:1973-9.
13. Zuckerman SH, Qureshi N. In vivo inhibition of lipopolysaccharide- induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction. Infect Immun 1992; 60:2581-7.
14. Szabo C, Thiemermann C, Wu CC, Perretti M, Vane JR. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA 1994; 91:271-5.
15. Muñoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88:1747-54.
16. Cabié A, Fitting C, Farkas J-C, et al. Influence of surgery on in-vitro cytokine production by human monocytes. Cytokine 1992; 4:576-80.
17. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL. Tolerance to endotoxin-induced expression of the interleukin-1β gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1993; 91:853-61.
18. van Deuren M, van der Ven-Jongekrijg H, Demacker PNM, et al. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 1994; 169:157-61.
19. Marie C, Muret J, Fitting C, Losser M-R, Payen D, Cavaillon J-M. Reduced ex vivo interleukin-8 production by neutrophils in septic and non-septic systemic inflammatory response syndrome. Blood 1998; 91: 3439-46.
20. Majetschak M, Flach R, Kreuzfelder E, et al. The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med 1999; 27:313-8.
21. Ziegler-Heitbrock HWL, Wedel A, Schraut W, et al. Tolerance to lipopolysaccharide involves mobilization of nuclear factor κB with predominance of p50 homodimers. J Biol Chem 1994; 269:17001-4.
22. Adib-Conquy M, Adrie C, Moine P, et al. NF-κB expression in mononuclear cells of septic patients resembles that observed in LPS-tolerance. Am J Respir Crit Care Med 2000; 162:1877-83.
23. Adib-Conquy M, Asehnoune K, Moine P, Cavaillon J-M. Longterm impaired expression of nuclear factor-κB and IκBα in peripheral blood mononuclear cells of patients with major trauma. J Leukoc Biol 2001; 70:30-8.
24. Granowitz EV, Porat R, Mier JW, et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 1993; 151:1637-45.
25. van der Poll T, Coyle SM, Moldawer LL, Lowry SF. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. J Infect Dis 1996; 174:1356-60.
26. Weijer S, Lauw FN, Branger J, van der Blink B, van der Poll T. Diminished interferon-γ production and responsiveness after endotoxin administration to healthy humans. J Infect Dis 2002; 186:1748-53.
27. Wakabayashi G, Cannon JG, Gelfand JA, et al. Altered interleukin-1 and tumor necrosis factor production and secretion during pyrogenic tolerance to LPS in rabbits. Am J Physiol 1994; 267:R329-36.
28. Flach R, Schade U. Peritoneal macrophages from endotoxin-tolerant mice produce an inhibitor of tumor necrosis factor synthesis and protect against endotoxin shock. J Endotoxin Res 1997; 4:241-50.
29. Fieren MWJA, Van den Bemd GJ, Bonta IL. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1β in vitro during infectious peritonitis. Eur J Clin Invest 1990; 20:453-7.
30. Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P, Scott H. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 1997; 112:1493-505.
31. Rana N, Braun DP, House R, Gebel H, Rotman C, Dmowski WP. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil Steril 1996; 65:925-30.
32. Wu MY, Ho HN, Chen SU, Chao KH, Chen CD, Yang YS. Increase in the production of IL-6, IL-10 and IL-12 by LPS stimulated peritoneal macrophages from women with endometriosis. Am J Reprod Immunol 1999; 41:106-11.
33. Jacobs RF, Tabor DR, Burks AW, Campbell GD. Elevated interleukin-1 release by human alveolar macrophages during adult respiratory distress syndrome. Am Rev Respir Dis 1989; 140:1686-92.
34. Cavaillon J-M, Adib-Conquy M, Cloëz-Tayarani I, Fitting C. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J Endotoxin Res 2001; 7:85-93.
35. Bailly S, Ferrua B, Fay M, Gougerot-Pocidalo MA. Differential regulation of IL-6, IL-1α, IL-1β and TNFα production in LPS stimulated human monocytes: role of cyclic AMP. Cytokine 1990; 2:205-10.
36. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R. In vivo imaging of NF-κB activity. J Immunol 2002; 168:1441-6.
37. Hacham M, Cristal N, White RM, Segal S, Apte RN. Complementary organ expression of IL-1 vs. IL-6 and CSF-1 activities in normal and LPS injected mice. Cytokine 1996; 8:21-31.
38. Tannahill CL, Fukuzuka K, Marum T, et al. Discordant tumor necrosis factor-α superfamily gene expression in bacterial peritonitis and endotoxemic shock. Surgery 1999; 126:349-57.
39. Stalder AK, Campbell IL. Simultaneous analysis of multiple cytokine receptor mRNAs protection assay in LPS-induced endotoxemia. Lymphokine Cytokine Res 1994; 13:107-12.
40. Boujoukos AJ, Martich GD, Supinski E, Suffredini AF. Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration. J Appl Physiol 1993; 74:3027-33.
41. Kabir K, Gelinas JP, Chen M, et al. Characterization of a murine model of endotoxin-induced acute lung injury. Shock 2002; 17:300-3.
42. Sheridan BC, Dinarello CA, Meldrum DR, Fullerton DA, Selzman CH, McIntyre RCJ. Interleukin-11 attenuates pulmonary inflammation and vasomotor dysfunction in endotoxin-induced lung injury. Am J Physiol 1999; 277:L861-7.
43. Vernooy JHJ, Dentener MA, van Suylen RJ, Buurman WA, Wouters EFM. Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol 2002; 26:152-9.
44. Corbel H, Theret N, Caulet-Maugendre S, et al. Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP2 and MMP9) activity. Inflamm Res 2001; 50:129-35.
45. Smith PD, Suffredini AF, Allen JB, Wahl LM, Parrillo JE, Wahl SM. Endotoxin administration to humans primes alveolar macrophages for increased production of inflammatory mediators. J Clin Immunol 1994; 14:141-8.
46. Salez L, Singer M, Balloy V, Creminon C, Chignard M. Lack of IL-10 synthesis by murine alveolar macrophages upon lipopolysaccharide exposure: comparison with peritoneal macrophages. J Leukoc Biol 2000; 67:545-52.
47. Zembala M, Siedlar M, Marcinkiewicz J, Pryjma J. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur J Immunol 1994; 24:435-9.
48. Flohé S, Ackerman M, Reuter M, Nast-Kolb D, Schade FU. Sublethal hemorrhagic shock reduced tumor necrosis factor producing capacity in different cell compartments. Eur Cytokine Netw 2000; 11:420-6.
49. Moynihan JA. Mechanisms of stress-induced modulation of immunity. Brain Behav Immun 2003; 17(Suppl 1):S11-6.
50. Abraham E. Effects of stress on cytokine production. Methods Achiev Exp Pathol 1991; 14:45-62.
51. Olszyna DP, De Jonge E, Dekkers PEP, van Deventer SJH, van der Poll T. Induction of cell-associated chemokines after endotoxin administration to healthy humans. Infect Immun 2001; 69:2736-8.
52. Marchant A, Alegre M, Hakim A, et al. Clinical and biological significance of interieukin-10 plasma levels in patients with septic shock. J Clin Immunol 1995; 15:266-73.
53. Ertel W, Kremer J, Kenney J, et al. Down-regulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995; 85:1341-7.
54. Cavaillon JM. The nonspecific nature of endotoxin tolerance. Trends Microbiol 1995; 3:320-4.
55. Nose M, Uzawa A, Nomura M, et al. Control of endotoxin shock by the dried preparation of low virulent Strepotococcus pyogenes OK-432. Cell Immunol 1998; 188:97-104.
56. Kreutz M, Ackerman U, Hauschildt S, et al. A comparative analysis of cytokine production and tolerance induction by bacterial lipopetides, lipopolysaccharides and Staphylocaccus aureus in human monocytes. Immunology 1997; 92:396-401.
57. Burkart V, Kim YE, Hartmann B, et al. Cholera toxin B pretreatment of macrophages and monocytes diminishes their proinflammatory responsiveness to lipopolysaccharide. J Immunol 2002; 168:1730-7.
58. Crabtree TD, Jin L, Raymond DP, et al. Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect Immun 2001; 69:2123-9.
59. Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different toll-like receptors independent of paracrine mediators. J Immunol 2001; 166:5161-7.
60. Cavailion J-M, Muñoz C, Marty C, et al. Cytokine production by monocytes from patients with sepsis syndrome and by endotoxin-tolerant monocytes. In: Levin J, Alving CR, Munford RS, Stütz PL, eds. Bacterial endotoxin: recognition and effector mechanisms. Amsterdam: Excerpta Medica, 1993:275-84.
61. Wilhelm W, Grundmann U, Rensing H, et al. Monocyte deactivation in severe human sepsis or following cardiopulmonary bypass. Shock 2002; 17:354-60.
62. Lemaire LC, van der Poll T, van Lanschot JJ, et al. Minimally invasive surgery induces endotoxin-tolerance in the absence of detectable endotoxemia. J Clin Immunol 1998; 18:414-20.
63. Astiz M, Saha D, Lustbader D, Lin R, Rackow E. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin Med 1996; 128: 594-600.
64. Bohuslav J, Kravchenko VV, Parry GCN, et al. Regulation of an essential innate immune response by the p50 subunit of NF-κB. J Clin Invest 1998; 102:1645-52.
65. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis like" syndrome. Circulation 2002; 106:562-8.
66. Adib-Conquy M, Moine P, Asehnoune K, et al. Toll-like receptor (TLR) 2-, TLR4-and TLR9-mediated TNF and IL-10 production are not similarly affected during systemic inflammation. Am J Resp Crit Care Med 2003; 168:158-64.
67. Hawes AS, Rock CS, Keogh CV, Lowry SF, Calvano SE. In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin. Infect Immun 1992; 60:2641-7.